MARKET

BIOA

BIOA

BioAge Labs Inc.
NASDAQ
5.55
-0.10
-1.77%
After Hours: 5.37 -0.18 -3.32% 19:53 11/13 EST
OPEN
5.87
PREV CLOSE
5.65
HIGH
5.87
LOW
5.39
VOLUME
427.50K
TURNOVER
--
52 WEEK HIGH
25.96
52 WEEK LOW
4.810
MARKET CAP
255.07M
P/E (TTM)
-2.1743
1D
5D
1M
3M
1Y
5Y
1D
BioAge Labs Is Maintained at Overweight by Piper Sandler
Dow Jones · 4d ago
BioAge Labs Price Target Cut to $40.00/Share From $73.00 by Piper Sandler
Dow Jones · 4d ago
BioAge Labs price target lowered to $40 from $73 at Piper Sandler
TipRanks · 4d ago
BioAge Labs Price Target Maintained With a $40.00/Share by BTIG
Dow Jones · 4d ago
Weekly Report: what happened at BIOA last week (1102-1106)?
Weekly Report · 4d ago
BioAge Labs GAAP EPS of -$0.73 misses by $0.09, revenue of $0.3M misses by $1.18M
Seeking Alpha · 11/06 05:25
BioAge Labs reports Q3 EPS (73c), consensus (63c)
TipRanks · 11/05 23:25
*BioAge Labs 3Q Loss $33.5M >BIOA
Dow Jones · 11/05 21:30
More
About BIOA
BioAge Labs, Inc. is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its lead product is BGE-102, a structurally novel, orally available small molecule NLRP3 inhibitor with high potency and brain penetration. In preclinical obesity models, BGE-102 resulted in weight loss as both a monotherapy and in combination with a GLP-1R agonist. Its pipeline includes novel, orally available, brain-penetrant small-molecule NLRP3 inhibitors to treat metabolic diseases and conditions driven by neuroinflammation, as well as novel APJ agonists for metabolic disorders. In preclinical obesity models, APJ agonism has demonstrated the ability to more than double the weight loss induced by a GLP-1R agonist while also restoring healthy body composition and improving muscle function.

Webull offers BioAge Labs, Inc. stock information, including NASDAQ: BIOA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BIOA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BIOA stock methods without spending real money on the virtual paper trading platform.